Medical Cannabis News

Synonyms: 
mmj
Thu
04
Jul

Natural health products jump on bandwagon of hype over endocannabinoid system

When it comes to cannabis and health, buzzwords abound: CBD and THC are chief among them, as well as the endocannabinoid system, which is the body's network of receptors that these cannabis compounds unlock.

Gaetano Morello, head of a Vancouver-based supplements company, is somewhat averse to that last one. He prefers to call it the body's "wellness system."

That's partly because of the unrelenting promotion that surrounds CBD these days, as myriad products in the legal and illegal market tout CBD-infused lotions, sprays, oils and lozenges that purport healing properties by unlocking the endocannabinoid system.

Wed
03
Jul

Medical Marijuana Inc (OTCMKTS:MJNA) issues an update on operational and financial results and participates in clinical trial of CBD based toothpaste and mouthwash

Medical Marijuana Inc (OTCMKTS:MJNA) has released a letter to the investors explaining the operational, financial results, and upcoming objectives.

Highlights

Medical Marijuana has summarized its three initiatives and one plant approach to benefit from the growth of CBD and Industrial hemp by becoming a leader in R&D of CBD based therapeutics, a global house of the brands, and a supplier of good quality cannabidiol raw materials on the global arena.

Wed
03
Jul

Cannabis use jumped 40 per cent in Canada between 2013 and 2017, UN report says

The United Nations' latest world drug report shows more Canadians started using cannabis each year in the lead-up to the drug's legalization for recreational use.

The report says there was a 40 per cent increase in usage of the drug between 2013 and 2017, which it attributes to a decrease in the perception of risk around cannabis use and the national debate around legalization.

It says the increase in Canada during this time was more pronounced in adults aged 20 or older, while it declined among young people aged 19 or younger.

According to the UN, Cannabis use overall is still higher among people between the ages of 15 and 24 than people who are 25 and older.

Fri
28
Jun

3 cannabis stocks with a competitive edge: Medical cannabis use safety

It’s no secret that cannabis plants offer various medical purposes. With the marijuana industry increasing as much as it has, there have been more treatment options surfacing, but adequate research is still lacking in some instances. As a result, cannabis stocks that focus the most on medical marijuana safety have been the ones gaining a competitive advantage in the market.

In this article, we’re going to look at three small-cap Canadian cannabis stocks that have a clinical trial advantage, choosing to focus on determining the medical benefits of cannabis rather than simply creating new products.

Fri
28
Jun

Ontario marks first PTSD Awareness Day: Is cannabis a viable treatment?

June 27 marks the first-ever Post-traumatic stress disorder Awareness Day in the province of Ontario.

Post-traumatic stress disorder (PTSD) is a mental health condition that is catalyzed by a traumatic occurrence an individual has witnessed or experienced. The memories or impressions of these events can have a serious and long-lasting impact on an individual’s life.

Fri
28
Jun

Store offering medical cannabis assessments opening in Owen Sound

The Capturing Eden Corporation, a unique line of stores offering medical cannabis assessments to underserviced areas in Ontario, is pleased to announce the opening of a new location in Owen Sound at 973 2nd Avenue West.

Stephen Barber, CEO of Capturing Eden Corp., said, “We decided to come to Owen Sound, as it is a greatly underserviced area that could be enhanced with proper medical cannabis assessments, as well as giving the opportunity for members of the community to purchase various hemp products.”

Thu
27
Jun

4 Canadian cannabis stocks with notable medical research growth

There are many conflicting opinions with regards to the safety of using medicinal cannabis.

The estimated 113 cannabinoids contained in cannabis plants offer varying medical purposes, however, most treatment options have not been effectively researched.

Companies that have focused on the efficacy and safety of using medicinal cannabis have gained a strong advantage in helping to educate patients and professionals on the use of cannabis. Today we have identified four Canadian cannabis stocks that have focused on clinical studies to determine the potential medical benefits of cannabis.

Wed
26
Jun

Tilray imports medical cannabis to U.K. after barriers are lifted

Tilray Inc. (TLRY.O) has imported its first bulk supply of medical cannabis oil into the U.K., after controversy over the confiscation of one of the Canadian company’s products led to an easing of restrictions.

The oral solution, containing both the psychoactive THC and non-intoxicating CBD compounds, is used to treat pain, chemotherapy-induced nausea and vomiting and multiple sclerosis-associated spasticity. It has already been supplied in bulk to Germany, Croatia, Cyprus and Malta.

Tue
25
Jun

What now after legal weed?

Testing for impairment from cannabis is no “magic bullet”. Rather, effective oversight, worker supervision and having an impairment-management program are key to navigating the post-legal-weed world. This was the message that Tom Brocklehurst, director of prevention practices and quality with WorkSafeBC in Richmond, Brit­ish Columbia, delivered during a session at the 2019 West­ern Conference on Safety in Vancouver.

“We are now six months after legalization. I don’t know if the sky has fallen — I don’t think it has,” Brocklehurst said. “Impairment has been around as long as there are impairing substances, and impaired workers have been around for as long as people have been working.”

Tue
25
Jun

Cannabis use could help prevent diabetes

A study published earlier this month shows data that identifies long term use of cannabis may prevent diabetes even after usage decreases or ends.

Researchers (Ngueta G. and Ndjaboue R.) from Laval University in Quebec analyzed data from the 2009-2016 National Health and Nutrition Examination Survey and estimated the minimal lifetime marijuana use using the duration of regular exposure and the frequency of use.

Researchers used linear models to determine the association of marijuana use with both fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR) for lean, overweight, and obese subjects.

Pages

Subscribe to RSS - Medical Cannabis News